Literature DB >> 8378257

Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone.

S A Charman1, K L Mason, W N Charman.   

Abstract

Three denaturing techniques have been evaluated for their ability to induce irreversible aggregation and precipitation of recombinant porcine growth hormone (pGH). The denaturing stimuli included thermal denaturation, interfacial denaturation through the introduction of a high air/water interface by vortex agitation, and a guanidine (Gdn) HCl technique which involved rapid dilution of a partially unfolded state of pGH to nondenaturing conditions. Soluble and insoluble pGH fractions were evaluated for the presence of covalently modified species and soluble aggregates by size exclusion chromatography (SEC), sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and isoelectric focusing (IEF). In each of the three denaturation methods, precipitation was found to be irreversible, as the precipitated pellet could not be solubilized upon resuspending in buffer. The soluble pGH fractions consisted of only monomeric material and the insoluble protein pellet could be completely solubilized with Gdn HCl or SDS. There was no evidence of detectable covalent modifications in the precipitated protein pellet following any of the three denaturation techniques. Three excipients, Tween 20, hydroxypropyl-beta-cyclodextrin (HPCD), and sorbitol were evaluated for their stabilizing ability using each of the three denaturation methods and the degree of stabilization was found to be dependent upon the denaturing stimulus incorporated. Tween 20 was found to be highly effective in preventing pGH precipitation using the interfacial and Gdn techniques and was moderately effective using the thermal denaturation method. Inclusion of HPCD in the sample buffer significantly reduced precipitation using the thermal and interfacial methods but was ineffective in the Gdn technique.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378257     DOI: 10.1023/a:1018994102218

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

Review 1.  Intermediates in the folding reactions of small proteins.

Authors:  P S Kim; R L Baldwin
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 2.  Adsorption of proteins from solution at the solid-liquid interface.

Authors:  W Norde
Journal:  Adv Colloid Interface Sci       Date:  1986-09       Impact factor: 12.984

Review 3.  Stability of protein structure and hydrophobic interaction.

Authors:  P L Privalov; S J Gill
Journal:  Adv Protein Chem       Date:  1988

Review 4.  Protein--solvent interactions in pharmaceutical formulations.

Authors:  T Arakawa; Y Kita; J F Carpenter
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

5.  The mechanisms of irreversible enzyme inactivation at 100C.

Authors:  T J Ahern; A M Klibanov
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

6.  Calorimetric study on thermal denaturation of lysozyme in polyol-water mixtures.

Authors:  K Gekko
Journal:  J Biochem       Date:  1982-04       Impact factor: 3.387

7.  Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.

Authors:  M E Brewster; M S Hora; J W Simpkins; N Bodor
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

8.  Increased thermal stability of proteins in the presence of sugars and polyols.

Authors:  J F Back; D Oakenfull; M B Smith
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

9.  Detergent-assisted refolding of guanidinium chloride-denatured rhodanese. The effects of the concentration and type of detergent.

Authors:  S Tandon; P M Horowitz
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

10.  Equilibrium denaturation of pituitary- and recombinant-derived bovine growth hormone.

Authors:  D N Brems; S M Plaisted; H A Havel; E W Kauffman; J D Stodola; L C Eaton; R D White
Journal:  Biochemistry       Date:  1985-12-17       Impact factor: 3.162

View more
  19 in total

1.  Inverse relationship of protein concentration and aggregation.

Authors:  Michael J Treuheit; Andrew A Kosky; David N Brems
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Stabilizing peptide fusion for solving the stability and solubility problems of therapeutic proteins.

Authors:  Eui Nam Lee; Young Mok Kim; Hye Ja Lee; Sang Woo Park; Han Young Jung; Jae Myun Lee; Yong-Ho Ahn; Jongsun Kim
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.

Authors:  Lili Wen; Xianxian Zheng; Xinyue Wang; Hairong Lan; Zongning Yin
Journal:  Pharm Res       Date:  2017-04-11       Impact factor: 4.200

Review 4.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

5.  Surface adsorption considerations when working with amyloid fibrils in multiwell plates and Eppendorf tubes.

Authors:  Amber N Murray; Fernando L Palhano; Jan Bieschke; Jeffery W Kelly
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

Review 6.  Considerations for the Use of Polysorbates in Biopharmaceuticals.

Authors:  Michael T Jones; Hanns-Christian Mahler; Sandeep Yadav; Dilbir Bindra; Vincent Corvari; R Matthew Fesinmeyer; Kapil Gupta; Alexander M Harmon; Kenneth D Hinds; Atanas Koulov; Wei Liu; Kevin Maloney; John Wang; Ping Y Yeh; Satish K Singh
Journal:  Pharm Res       Date:  2018-05-24       Impact factor: 4.200

7.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

Review 8.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

9.  The role of polysorbate 80 and HPβCD at the air-water interface of IgG solutions.

Authors:  Tim Serno; Elisabeth Härtl; Ahmed Besheer; Reinhard Miller; Gerhard Winter
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

10.  Opposite effects of polyols on antibody aggregation: thermal versus mechanical stresses.

Authors:  Shermeen A Abbas; Vikas K Sharma; Thomas W Patapoff; Devendra S Kalonia
Journal:  Pharm Res       Date:  2011-09-27       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.